1 hour ago $GLSI released the results from their phase 2 trials - 0 Breast Cancer reoccurences and immediate phase 3 push
Greenwich Lifesciences (GLSI) has already ran up like crazy over the week which is great. Tomorrow ought to be a great day which is great. GLSI has a very low float so I hope the money is great.
But even better...
Breast cancer just took a kick in the teeth!!
After testing in almost 200 subjects none of them had reoccurences. Even one with the most aggressive forms of beast cancer.
You can find all of the info here as well as a 2 min audio explanation from the man himself: https://greenwichlifesciences.com/clinical-trials/
Link to abstract - https://www.abstractsonline.com/pp8/#!/9325/presentation/5254